|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar
|
|
2
|
Hemminki A, Markie D, Tomlinson I, et al:
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.
Nature. 391:184–187. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jenne DE, Reomann H, Nezu J, et al:
Peutz-Jeghers syndrome is caused by mutations in a novel serine
threonine kinase. Nat Genet. 18:38–43. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smith DP, Spicer J, Smith A, Swift S and
Ashworth A: The mouse Peutz-Jeghers syndrome gene Lkbl
encodes a nuclear protein kinase. Hum Mol Genet. 8:1479–1485. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boudeau J, Kieloch A, Alessi DR, Stella A,
Guanti G and Resta N: Functional analysis of LKB1/STK11 mutants and
two aberrant isoforms found in Peutz-Jeghers syndrome patients. Hum
Mutat. 21:1722003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shackelford DB and Shaw RJ: The LKB1-AMPK
pathway: metabolism and growth control in tumour suppression. Nat
Rev Cancer. 9:563–575. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kahn BB, Alquier T, Carling D and Hardie
DG: AMP-activated protein kinase: ancient energy gauge provides
clues to modern understanding of metabolism. Cell Metab. 1:15–25.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baas AF, Boudeau J, Sapkota GP, et al:
Activation of the tumour suppressor kinase LKB1 by the STE20-like
pseudokinase STRAD. EMBO J. 22:3062–3072. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakada D, Saunders TL and Morrison SJ:
Lkb1 regulates cell cycle and energy metabolism in haematopoietic
stem cells. Nature. 468:653–658. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jansen M, Ten Klooster JP, Offerhaus GJ
and Clevers H: LKB1 and AMPK family signaling: the intimate link
between cell polarity and energy metabolism. Physiol Rev.
89:777–798. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji H, Ramsey MR, Hayes DN, et al: LKB1
modulates lung cancer differentiation and metastasis. Nature.
448:807–810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kroemer G, Mariño G and Levine B:
Autophagy and the integrated stress response. Mol Cell. 40:280–293.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Carew JS, Nawrocki ST, Kahue CN, et al:
Targeting autophagy augments the anticancer activity of the histone
deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug
resistance. Blood. 110:313–322. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Michaud M, Martins I, Sukkurwala AQ, et
al: Autophagy-dependent anticancer immune responses induced by
chemotherapeutic agents in mice. Science. 334:1573–1577. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Moretti L, Yang ES, Kim KW and Lu B:
Autophagy signaling in cancer and its potential as novel target to
improve anticancer therapy. Drug Resist Updat. 10:135–143. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu YL, Yang PM, Shun CT, Wu MS, Weng JR
and Chen CC: Autophagy potentiates the anti-cancer effects of the
histone deacetylase inhibitors in hepatocellular carcinoma.
Autophagy. 6:1057–1065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi AM, Ryter SW and Levine B: Autophagy
in human health and disease. N Engl J Med. 368:651–662. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wrighton KH: Autophagy: kinase crosstalk
through beclin 1. Nat Rev Mol Cell Biol. 14:402–403. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Won KY, Kim GY, Kim YW, Song JY and Lim
SJ: Clinicopathologic correlation of beclin-1 and bcl-2 expression
in human breast cancer. Hum Pathol. 41:107–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Y, Lu Y, Lu C and Zhang L: Beclin-1
expression is a predictor of clinical outcome in patients with
esophageal squamous cell carcinoma and correlated to
hypoxia-inducible factor (HIF)-1α expression. Pathol Oncol Res.
15:487–493. 2009.PubMed/NCBI
|
|
22
|
Ahn CH, Jeong EG, Lee JW, et al:
Expression of beclin-1, an autophagy-related protein, in gastric
and colorectal cancers. APMIS. 115:1344–1349. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen N and Karantza V: Autophagy as a
therapeutic target in cancer. Cancer Biol Ther. 11:157–168. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen S, Rehman SK, Zhang W, Wen A, Yao L
and Zhang J: Autophagy is a therapeutic target in anticancer drug
resistance. Biochim Biophys Acta. 1806:220–229. 2010.PubMed/NCBI
|
|
25
|
Alexander A and Walker CL: The role of
LKB1 and AMPK in cellular responses to stress and damage. FEBS
Lett. 585:952–957. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shackelford DB, Abt E, Gerken L, et al:
LKB1 inactivation dictates therapeutic response of non-small cell
lung cancer to the metabolism drug phenformin. Cancer Cell.
23:143–158. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sanchez-Cespedes M, Parrella P, Esteller
M, et al: Inactivation of LKB1/STK11 is a common event in
adenocarcinomas of the lung. Cancer Res. 62:3659–3662.
2002.PubMed/NCBI
|
|
29
|
Nakada Y, Stewart TG, Peña CG, et al: The
LKB1 tumor suppressor as a biomarker in mouse and human tissues.
PLoS One. 8:e734492013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsumoto S, Iwakawa R, Takahashi K, et
al: Prevalence and specificity of LKB1 genetic alterations
in lung cancers. Oncogene. 26:5911–5918. 2007.
|
|
31
|
Wingo SN, Gallardo TD, Akbay EA, et al:
Somatic LKB1 mutations promote cervical cancer progression.
PLoS One. 4:e51372009.
|
|
32
|
Su GH, Hruban RH, Bansal RK, et al:
Germline and somatic mutations of the STK11/LKB1
Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol.
154:1835–1840. 1999.PubMed/NCBI
|
|
33
|
Rowan A, Bataille V, MacKie R, et al:
Somatic mutations in the Peutz-Jegners (LKB1/STKII) gene in
sporadic malignant melanomas. J Invest Dermatol. 112:509–511. 1999.
View Article : Google Scholar
|
|
34
|
Nakau M, Miyoshi H, Seldin MF, Imamura M,
Oshima M and Taketo MM: Hepatocellular carcinoma caused by loss of
heterozygosity in Lkb1 gene knockout mice. Cancer Res.
62:4549–4553. 2002.PubMed/NCBI
|
|
35
|
Miyoshi H, Nakau M, Ishikawa TO, Seldin
MF, Oshima M and Taketo MM: Gastrointestinal hamartomatous
polyposis in Lkb1 heterozygous knockout mice. Cancer Res.
62:2261–2266. 2002.PubMed/NCBI
|
|
36
|
McCarthy A, Lord CJ, Savage K, et al:
Conditional deletion of the Lkb1 gene in the mouse mammary
gland induces tumour formation. J Pathol. 219:306–316. 2009.
|
|
37
|
Onozato R, Kosaka T, Achiwa H, et al:
LKB1 gene mutations in Japanese lung cancer patients. Cancer
Sci. 98:1747–1751. 2007. View Article : Google Scholar
|
|
38
|
Klionsky DJ and Emr SD: Autophagy as a
regulated pathway of cellular degradation. Science. 290:1717–1721.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu J, Lin Y, Yang H, Deng Q, Chen G and
He J: The expression of p33(ING1), p53, and autophagy-related gene
Beclin1 in patients with non-small cell lung cancer. Tumour Biol.
32:1113–1121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim KM, Yu TK, Chu HH, et al: Expression
of ER stress and autophagy-related molecules in human non-small
cell lung cancer and premalignant lesions. Int J Cancer.
131:E362–E370. 2012. View Article : Google Scholar : PubMed/NCBI
|
